Literature DB >> 17610243

Combinatorial synthesis, reversed-phase and normal-phase high-performance liquid chromatography elution data and liquid chromatography/positive atmospheric pressure chemical ionization tandem mass spectra of methoxylated and glycosylated resveratrol analogues.

Vesna Jerkovic1, Fanny Nguyen, Sabrina Nizet, Sonia Collin.   

Abstract

Analyses of methoxylated and glycosylated stilbenes remain scarce in the literature because of the commercial unavailability of these compounds. Here a library of 22 compounds was synthesized by combinatorial chemistry. Their elution profiles were compared on three different columns (C18, C8, and silica) with those of seven commercial resveratrol analogues and two viniferins. The spectra recorded by liquid chromatography/positive atmospheric pressure chemical ionization tandem mass spectrometry (LC-APCI(+)-MS/MS) are discussed and recommendations made for easier identification of new stilbenes. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610243     DOI: 10.1002/rcm.3116

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  3 in total

1.  Disclosing the Molecular Basis of the Postharvest Life of Berry in Different Grapevine Genotypes.

Authors:  Sara Zenoni; Marianna Fasoli; Flavia Guzzo; Silvia Dal Santo; Alessandra Amato; Andrea Anesi; Mauro Commisso; Markus Herderich; Stefania Ceoldo; Linda Avesani; Mario Pezzotti; Giovanni Battista Tornielli
Journal:  Plant Physiol       Date:  2016-09-26       Impact factor: 8.340

2.  Study of Grape Polyphenols by Liquid Chromatography-High-Resolution Mass Spectrometry (UHPLC/QTOF) and Suspect Screening Analysis.

Authors:  Riccardo Flamini; Mirko De Rosso; Luigi Bavaresco
Journal:  J Anal Methods Chem       Date:  2015-02-04       Impact factor: 2.193

3.  Pharmacometrics of 3-methoxypterostilbene: a component of traditional chinese medicinal plants.

Authors:  Stephanie E Martinez; Casey L Sayre; Neal M Davies
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-16       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.